ZERBE ROBERT L MD sold 8.6% of their position (2.50K shares) of VERICEL CORP on the open market
Open‑market sale worth $156.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/7/2025ACC: 0001140361-25-003571
+2.50K
Net shares
Net buyer
$156.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
5K acquired · 2.50K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.50K
Price / share
$13.05
Trade value
$32.63K
% of position
9.4%
2/5/2025
26.59K→29.09K
Common Stock
Direct
Shares
−2.50K
Price / share
$62.50
Trade value
$156.25K
% of position
8.6%
2/5/2025
29.09K→26.59K
Total
Net shares
+0.00
Net value
-$123.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/5/2025 | M · Option Exercise | +2.50K | $13.05 | $32.63K | 9.4% | 26.59K | 29.09K |
| Common Stock Direct | 2/5/2025 | S · Sale | −2.50K | $62.50 | $156.25K | 8.6% | 29.09K | 26.59K |
| Total | +0.00 | -$123.63K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
2.50K shares
Shares
+2.50K
Strike price
13.05
Held after
7.50K
Exercisable
—
2/5/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock2.50K shares | 2/5/2025 | M · Option Exercise | +2.50K | 13.05 | — | 7.50K |